Chugai Pharmaceutical Co., Ltd.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Chugai Pharmaceutical Co., Ltd.'s balance sheet done over the years? Its assets were worth $1,932,547,000,000 last year, which is more than in the previous period. 16% of Chugai Pharmaceutical Co., Ltd.’s total assets is currently financed by debt. Its liabilities reached the amount of $306,967,000,000, which means an decrease by -31% compared compared to last year.
Debt to Assets
| 2014 | 739538000000 | 141.78B | 19.17% |
|---|---|---|---|
| 2015 | 787401000000 | 160.13B | 20.34% |
| 2016 | 806285000000 | 159.78B | 19.82% |
| 2017 | 852473000000 | 159.57B | 18.72% |
| 2018 | 919548000000 | 163.02B | 17.73% |
| 2019 | 1058915000000 | 204.93B | 19.35% |
| 2020 | 1235498000000 | 255.49B | 20.68% |
| 2021 | 1538694000000 | 350.67B | 22.79% |
| 2022 | 1869758000000 | 445.37B | 23.82% |
| 2023 | 1932547000000 | 306.96B | 15.88% |
CHGCY Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 458.67B | 222.16B | 267.75B | 212.33B | 203.94B | 146.86B | 139.07B | 95.36B | 101.70B | 114.03B |
Short term investments | 280.30B | 280.93B | 204.21B | 166.28B | 129.11B | 102.53B | 104.01B | 110.17B | 134.41B | 116.03B |
Net receivables | 318.89B | 514.28B | 356.00B | 253.35B | 181.64B | 179.55B | 175.00B | 167.48B | 158.71B | 159.88B |
Inventory | 273.48B | 292.20B | 208.83B | 183.89B | 168.12B | 159.36B | 169.05B | 185.44B | 161.13B | 139.57B |
Other current assets | 35.07B | 26.94B | 26.84B | 19.03B | 16.85B | 11.78B | 12.70B | 20.29B | 11.84B | 27.92B |
Total current assets | 1.36T | 1.33T | 1.06T | 834.90B | 699.68B | 600.09B | 599.14B | 578.76B | 567.77B | 538.90B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 420.70B | 386.65B | 352.10B | 297.49B | 265.30B | 222.38B | 171.56B | 157.08B | 153.54B | 140.24B |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 19.86B | 25.14B | 21.97B | 23.88B | 23.54B | 22.69B | 21.07B | 19.29B | 13.51B | 11.28B |
Long term investments | 61.08B | -279.10B | -201.82B | -163.44B | -126.15B | -92.81B | -92.66B | -100.47B | -120.70B | -105.27B |
Other non-current assets | 64.47B | 335.28B | 246.48B | 194.73B | 153.86B | 131.61B | 118.85B | 124.14B | 147.25B | 128.70B |
Total non-current assets | 566.12B | 533.22B | 475.03B | 400.59B | 359.23B | 319.45B | 253.33B | 227.52B | 219.62B | 200.63B |
Total assets | 1.93T | 1.86T | 1.53T | 1.23T | 1.05T | 919.54B | 852.47B | 806.28B | 787.40B | 739.53B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 79M | 86M | 80M | 252M | 19.56B | 18.62B | 10.60B | 13.31B | 17.60B |
Short term debt | 0 | 6.43B | 6.55B | 6.64B | 7.26B | 133M | -18.49B | 135M | -13.18B | 29M |
Total current liabilities | 288.21B | 423.73B | 327.42B | 236.07B | 179.26B | 135.21B | 122.90B | 123.66B | 133.05B | 114.35B |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | -430M | -490M | -564M | -643M | 82M | 207M | 510M | 604M | 185M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 18.37B | 14.55B | 15.64B | 10.25B | 16.35B | 1.94B | 25.13B | 15.54B | 22.13B | 22.52B |
Total non-current liabilities | 18.75B | 21.64B | 23.25B | 19.42B | 25.66B | 27.80B | 36.67B | 36.12B | 27.07B | 27.43B |
Total liabilities | 306.96B | 445.37B | 350.67B | 255.49B | 204.93B | 163.02B | 159.57B | 159.78B | 160.13B | 141.78B |